Drug intelligence / Profile preview

Ma Xing Shi Gan Tang

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral
01

Overview

Ma Xing Shi Gan Tang is a classical Chinese herbal formula composed of four main ingredients: Ephedra stem (Ma Huang), Gypsum (Shi Gao), Apricot kernel (Xing Ren), and Honey-fried Licorice root (Zhi Gan Cao)[1][6]. It was first described in the ancient text "On Cold Damage" (Shang Han Lun) around 220 AD[1][6]. The formula is traditionally used to clear heat from the lungs, facilitate the flow of Lung Qi, stop cough and wheezing by directing rebellious Qi downward[1][4][6]. Its primary indications include symptoms such as high fever with or without sweating, thirst with dry throat, cough with thin yellow sputum or labored breathing/wheezing—often associated with conditions like upper respiratory tract infections and pneumonia[1][3][6]. Modern research has shown that Ma Xing Shi Gan Tang exhibits antibacterial activity against pathogens such as Streptococcus pneumoniae by targeting pneumolysin—a key virulence factor—suggesting a mechanism involving inhibition of bacterial toxins in addition to its traditional anti-inflammatory effects[3]. The formula is sometimes used for bronchial asthma and other lung heat syndromes in both adults and children[6].

Brand names
Ma Xing Shi Gan TangEphedra Apricot Kernel Gypsum and Licorice DecoctionEphedra Apricot Kernel Licorice and Gypsum DecoctionM.H. & Apricot Combination GranulesMa Xing Gan Shi Tang Capsules
Other names
麻杏石甘汤Má Xìng Shí Gān TāngMahuang & Apricot Seed Combination
02

Targets

Ply (Pneumolysin)TRPV1 (Transient receptor potential cation channel subfamily V member 1)SMPD1 (Acid sphingomyelinase)

Beyond the preview

Go deeper on Ma Xing Shi Gan Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ma Xing Shi Gan Tang.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call